|Report ID : RC-10841||Category : Healthcare||Published Date : 31.08.2018|
|Publisher : Rockville||Pages : 96||Format : PDF|
FDA has recently approved much-awaited first dedicated coronary bifurcated stent for treatment of cardiovascular diseases. The report ?Global Coronary Artery Stent ? Focus on Bioresorbable Stents Market Outlook 2024? provides information on the current scenario, market outlook of the global coronary artery stents market with detailed analysis of bioresorbable stents. The market is further analyzed with detailed market outlook for global as well as regional markets such as North America, Europe and Asia Pacific. Market outlook for overall market as well as for various segments for aforementioned regions has been provided for the period 2018-24. The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global coronary artery stents market. The report has been segmented as following:- Market Segments ? Coronary Artery Stents ? Bioresorbable stents Geographical Coverage ? North America - The US ? Europe ? Asia Pacific Companies Coverage ? Abbott Laboratories ? Medtronic PLC ? Boston Scientific Corporation ? REVA Medical ? Biotronik, Inc.
1. Executive Summary 2. Research Methodology 3. Coronary Artery Stents 3.1 Background 3.2 Overview 3.3 Classification 3.3.1 Bare Metal Stent (BMS) 3.3.2 Drug-eluting stents (DES) 3.3.3 Bioresorbable stents (BRS) 4. Market Analysis 4.1 Market Sizing (Actual & Foreacsted) 4.2 Market Share Analysis 4.2.1 Market Share by Types 4.2.2 Market Share by Region 4.3 Pricing Trend 5. Bioresorbable Stents 5.1 Overview 5.2 Market Sizing (Actual & Forecasted) 5.3 Market Share Analysis 5.3.1 Market Share by Type of Material 5.3.2 Market Share by Application 5.3.3 Market Share by Absorption Rate 5.3.4 Market Share by Region 6. Regional Analysis 6.1 North America 6.1.1 Coronary Stent Market Sizing (Actual & Forecasted) 6.1.2 Market Share by Stent Type 6.1.3 Bioabsorbable Stent Market Sizing (Actual & Forecasted) 6.1.4 The US 220.127.116.11 Stent Market Sizing (Actual & Forecasted) 18.104.22.168 Market Share by Products 22.214.171.124 Bioabsorbable Stent Market Sizing (Actual & Forecasted) 6.2 Europe 6.2.1 Coronary Stent Market Sizing (Actual & Forecasted) 6.2.2 Market Share by Stent Type 6.2.3 Bioabsorbable Stent Market Sizing (Actual & Forecasted) 6.3 Asia Pacific 6.3.1 Coronary Stent Market Sizing (Actual & Forecasted) 6.3.2 Market Share by Stent Type 6.3.3 Bioabsorbable Stent Market Sizing (Actual & Forecasted) 7. Market Dynamics 7.1 Industry Trend & Development 7.1.1 Use of Premium Alloys for Stenting 7.1.3 Advent of X-Ray Visible Absorbable Embolic Bead 7.1.4 FDA Approval of First Dedicated Coronary Bifurcation Stent 7.2 Growth Drivers 7.2.1 Increasing Geriatric Population 7.2.2 Prevalence of Coronary & Peripheral Artery Diseases 7.2.3 Favorable Reimbursement Policies 7.3 Challenges 7.3.1 Stringent Regulations 7.3.2 Post-Operative Complications 7.3.3 Slow Adoption Rate 7.3.4 High Cost of Devices 8. Competitive Landscape 8.1 Coronary Stents 8.1.1 Market Share Analysis 8.2 Bioresorbable Stents 8.2.1 Market Share Analysis 8.2.2 Brand Analysis 9. Company Profiles 9.1 Abbott Laboratories 9.2 Medtronic PLC 9.3 Boston Scientific Corporation 9.4 REVA Medical 9.5 Biotronik Inc.
Akasaka biz tower,
5-3-1 akasaka minato-ku,